Furthermore, Cef can ameliorate tau pathological changes and cognitive impairment by promoting the glutamate transporters in 3xTg AD model (Zumkehr et al., 2015) and long-term potentiation impairment and paired-pulse responses in OKA-induced AD model (Hamidi et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.